Treating The Common Cold: An Expert Panel Consensus Recommendation for Primary Care Clinicians

References

1. Gonzales R, Malone DC, Maselli JH, et al. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis. 2001;33:757-762.

2. Mainous AG, Hueston WJ. The cost of antibiotics in treating upper respiratory tract infections in a Medicaid population. Arch Fam Med. 1998;7(1):51-52.

3. Messerschmidt K. Natural alternatives for the common cold: hype or hope? S D J Med. 2001;54(3):93-94.

4. Adams PF, Hendershot GE, Marano MA. Current estimates for the National Health Interview Survey. Vital Health Stat. 1999;10:1996.

5. Holmberg M, Schott MK. "Oh no, not another one"—treatment and prevention of the common cold. Pharm Times. 2003;69 (12):81-88.

6. Snow V, Mottur-Pilson C, Gonzales R. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections. Ann Intern Med. 2001;134 (6):487-489.

7. Heikkinen T, Jarvinen A. The common cold. Lancet. 2003;361:51-59.

8. Turner RB. Epidemiology, pathogenesis, and treatment of the common cold. Ann Allergy Asthma Immunol. 1997;78(6):531-540.

9. Tietze KJ. Disorders related to cold and allergy. In: Berardi RR, ed. Handbook of Nonprescription Drugs. 14th ed. Washington, DC: American Pharmacists Association; 2004:239-269.

10. Ball TM, Holberg CJ, Aldous MB, et al. Influence of attendance at day care on the common cold from birth through 13 years of age. Arch Pediatr Adolesc Med. 2002;156(2): 121-126.

11. Wald ER, Dashefsky B, Byers C, et al. Frequency and severity of infections in day care. J Pediatr. 1988;112(4):540-546.

12. Cohen S, Tyrrell DA, Smith AP. Psychological stress and susceptibility to the common cold. N Engl J Med. 1991;325(9): 606-612.

13. Nieman DC. Exercise, upper respiratory tract infection, and the immune system. Med Sci Sports Exerc. 1994; 26(2):128-139.

14. Cauwenberge PBV, Kempen MJV, Bachert C. The common cold at the turn of the millennium. Am J Rhinol. 2000; 14(5): 339-343.

15. Winther B, Gwaltney JM, Mygind N, et al. Sites of rhinovirus recovery after point inoculation of the upper airway. JAMA. 1986;256(13):1763-1767.

16. Winther B, Greve JM, Gwaltney JM, et al. Surface expression of intercellular adhesion molecule 1 on epithelial cells in the human adenoid. J Infect Dis. 1997;176(2): 523-525.

17. Hendley JO, Gwaltney JM. Mechanisms of transmission of rhinovirus infection. Epidemiol Rev. 1988;10:243-258.

18. Harris JM, Gwaltney JM. The incubation periods of experimental rhinovirus infection and illness. Clin Infect Dis. 1996; 23(6):1287-1290.

19. Gwaltney JM, Hayden FG. Psychological stress and the common cold. N Engl J Med. 1992;326(9):644-646.

20. Winther B, Brofeldt S, Gronborg H, et al. Study of bacteria in the nasal cavity and nasopharynx during naturally acquired common colds. Acta Otolaryngol. 1984;98(3-4): 315-320.

21. Lanza DC, Kennedy DW. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg. 1997;117(3 pt 2):S1-S7.

22. Vital and Health Statistics. National Ambulatory Medical Care Survey. Rockville, Md: US Department of Health and Human Services; 1994. DHHS publication 94-1777.

23. Sinus and Allergy Health Partnership. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg. 2000;123(1 pt 2):S1-S32.

24. Casiano R. Managing rhinosinusitis: an ENT physician's perspective. J Respir Dis. 1999;20:S35-S42.

25. Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. J Allergy Clin Immunol. 2001;107(1):3-8.

26. Bisno A, Gerber M, Gwaltney JJ, et al. Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Clin Infect Dis. 1997;25:574-583.

27. Pichichero M. Group A streptococcal tonsillopharyngitis: cost-effective diagnosis and treatment. Ann Emerg Med. 1995;25: 390-403.

28. Bisno A. Streptococcus pyogenes. In: Mandell GL, Douglas RG, Bennet JE, eds. Principles and Practice of Infectious Diseases. 3rd ed. New York, NY: Churchill Livingstone; 1990:1519-1528.

29. Schwartz B, Marcy M, Phillips WR, et al. Pharyngitis' principles of judicious use of antimicrobial agents. Pediatrics. 1998; 101:171-174.

30. Hemila H. Vitamin C intake and susceptibility to the common cold. Br J Nutr. 1997;77:59-72.

31. Douglas RG, Lindgren KM, Couch RB. Exposure to cold environment and rhinovirus common cold. N Engl J Med. 1968;279(14):742-747.

32. Zitter JN, Mazonson PD, Miller DP. Aircraft cabin air recirculation and symptoms of the common cold. JAMA. 2002;288:483-486.

33. Meadows M. Beat the winter bugs: how to hold your own against colds and flu. FDA Consum. 2001;35:11-18.

34. Stay active to stay cold-free. Natural Health. 2003;33:30.

35. Gwaltney JM. Clinical significance and pathogenesis of viral respiratory infections. Am J Med. 2002;112 (6A):13S-18S.

36. Rennard BO, Ertl RF, Gossman GL, et al. Chicken soup inhibits neutrophil chemotaxis in vitro. Chest. 2000;118(4):1150-1157.

37. Weidner TG. The effect of exercise training on the severity and duration of viral upper respiratory illness. Med Sci Sports Exerc. 1998;30(11):1578-1583.

38. eHow, Inc. How things get done. How to blow your nose. Available at: http://www.ehow.com/how_9504_blow-nose.html.

39. Common cold. In: Covington TR, ed. Nonprescription Drug Therapy. St Louis, Mo: Facts & Comparisons; 2002:743-769.

40. Lee PC, Jawad MS, Eccles R. Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory tract infections. J Pharm Pharmacol. 2000; 52:1137-1142.

41. Freestone C, Eccles R. Assessment of the antitussive efficacy of codeine in cough associated with common cold. J Pharm Pharmacol. 1997;49:1045-1049.

42. Dextromethorphan. In: Tatro DS, ed. Drug Interaction Facts. St Louis, Mo: Wolters Kluwer Health; 2005.

43. DiMarco MP, Edwards DJ, Ducharme MP. The effect of grapefruit juice and Seville orange juice on the pharmacokinetics of dextromethorphan: the role of CYP3A and P-glycoprotein. Life Sci. 2002;71(10):1149-1160.

44. Kuhn JJ, Hendley JO, Adams KF, et al. Antitussive effect of guaifenesin in young adults with natural colds. Chest. 1982; 82(6):713-718.

45. Schroeder DJ, Hart LL, Miyagi SL. Zinc lozenges for treatment of common colds. Ann Pharmacother. 1993;27:589-592.

46. Eby, GA. Zinc ion availability—the determinant of efficacy in zinc lozenge treatment of common colds. J Antimicrob Chemother. 1997;40:483-493.

47. King JC, Keen CL. Zinc. In: Shils M, Olson JA, Shike M, et al, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, Md: Williams & Wilkins; 1999.

48. Eby GA, Davis DR, Halcomb WW. Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study. Antimicrob Agents Chemother. 1984; 25:20-24.

49. Garland ML, Hagmeyer KO. The role of zinc lozenges in treatment of the common cold. Ann Pharmacother. 1998;32(1):63-69.

50. Prasad A, Fitzgerald JT, Bao B, et al. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. Ann Intern Med. 2000;133(4):245-252.

51. McElroy BH, Miller SP. An open-label, single-center, phase IV clinical study of the effectiveness of zinc gluconate glycine lozenges (Cold-Eeze) in reducing the duration and symptoms of the common cold in school-aged subjects. Am J Ther. 2003; 10(5): 324-329.

52. Marshall I. Zinc for the common cold (Cochrane Review). The Cochrane Library, Issue 3, 2004. Chichester, UK: John Wiley & Sons, Ltd.

53. Hulisz D. Efficacy of zinc against common cold viruses: an overview. J Am Pharm Assoc. 2004;44(5):594-603.

54. Aamodt RL, Rumble WF, Johnston GS, et al. Absorption of orally administered 65Zn by normal human subjects. Am J Clin Nutr. 1981;34:2648-2652.

55. Jafek BW, Linchoten MR, Murrow BW. Anosmia after intranasal zinc gluconate. Am J Rhinol. 2004;18(3):137-141.

56. Douglas RM, Chalker EB, Treacy B. Vitamin C for preventing and treating the common cold (Cochrane Review). The Cochrane Library, Issue 3, 2004. Chichester, UK: John Wiley & Sons, Ltd.

57. Audera C, Patulny RV, Sander BH, et al. Mega-dose vitamin C treatment of the common cold: a randomised controlled trial. Med J Aust. 2001;175(7):359-362.

58. Barrett B, Vohmann M, Calabrese C. Echinacea for upper respiratory infection. J Fam Pract. 1999;48(8):628-635.

59. Giles JT, Palat CT, Chien SH, et al. Evaluation of echinacea for treatment of the common cold. Pharmacotherapy. 2000;20(6): 690-697.

60. Melchart D, Linde K, Fisher P, et al. Echinacea for preventing and treating the common cold (Cochrane Review). The Cochrane Library, Issue 3, 2004. Chichester, UK: John Wiley & Sons, Ltd.

61. Barrett BP, Brown RL, Locken K, et al. Treatment of the common cold with unrefined echinacea: a randomised, double-blind, placebo-controlled trial. Ann Intern Med. 2002;137:939-946.

62. Turner R. Echinacea for the common cold: can alternative medicine be evidence-based medicine? Ann Intern Med. 2002; 137:1001-1002.

63. Gonzales R, Bartlett JC, Bessner RE, et al. Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med. 2001;134(6):479-486.

64. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA. 1997;278:901-904.

65. Butler JC, Hofmann J, Cetron MS, et al. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect Dis. 1996;174:986-993.

66. Gonzales R, Bartlett JG, Besser RE, et al. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. Ann Intern Med. 2001;134(6):490-494.

67. Rosenstein N, Phillips WR, Gerber MA, et al. The common cold-principles of judicious use of antimicrobial agents. Pediatrics. 1998;101:181-184.

68. Braun B, Fowles J. Characteristics and experiences of parents and adults who want antibiotics for cold symptoms. Arch Fam Med. 2000;9:589-595.

69. Dowell SF, Marcy SM, Phillips WR, et al. Principles of judicious use of antimicrobial agents for pediatric upper respiratory tract infections. Pediatrics. 1998;101:163-165.

70. Bauman K. The family physician's reasonable approach to upper respiratory tract infection care for this century. Arch Fam Med. 2000;9:596-597.

71. Centers for Disease Control and Prevention. Get smart: know when antibiotics work. Available at www.cdc/gov/drug resistance/community.